In AML in particular, a number of studies with human cells and xenograft mouse models have recently suggested that HIF-1α and HIF-2α play pro-leukemogenic functions by regulating leukemia progression and maintenance of leukemia initiating cells (LICs). Here, EPAS1 is linked to leukemia.